Trial Profile
To investigate the correlation between the occurrence of vitiligo and clinical benefit of nivolumab treatment in advanced melanoma patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Mar 2018
Price :
$35
*
At a glance
- Drugs Nivolumab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 28 Mar 2018 New trial record